Nonalcoholic Fatty Liver Disease (NAFLD)
Conditions
Interventions
Healthy control group:None
Low dose lycopene intervention group:20 mg/d lycopene
High dose lycopene intervention group:40 mg/d lycopene
Sponsors
Qingdao University
Eligibility
Sex/Gender
All
Age
30 Years to 60 Years
Inclusion criteria
Inclusion criteria: According to the diagnostic criteria of the Guidelines for the Diagnosis and Treatment of Non-alcoholic Fatty Liver Disease (NAFLD) revised in 2010 by fatty liver and alcoholic liver Disease Group of Liver Association of Chinese Medical Association, 30-60 years old non-alcoholic fatty liver disease (NAFLD) patients were selected.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of liver damage medication; 2. The Subject of drinking; 3. Patients with viral hepatitis; 4. Patients with autoimmune liver disease; 5. Patients with anemia, cardiovascular and cerebrovascular diseases and other system diseases; 6. Patients with hemochromatosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin;Serum ferritin;Serum iron;Soluble transferrin receptor;Alanine aminotransferase;Aspartate aminotransferase;Total protein;Albumin;Hepcidin;Hemojuvelin;Height;Weight;Waist circumference;Hip circumference;Abdominal circumference; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory cytokines; | — |
Countries
China
Contacts
Public ContactYongye Sun
School of Public Health, Qingdao University
Outcome results
None listed